Your browser doesn't support javascript.
loading
Human Airway Epithelium Responses to Invasive Fungal Infections: A Critical Partner in Innate Immunity.
Crossen, Arianne J; Ward, Rebecca A; Reedy, Jennifer L; Surve, Manalee V; Klein, Bruce S; Rajagopal, Jayaraj; Vyas, Jatin M.
Afiliação
  • Crossen AJ; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Ward RA; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Reedy JL; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Surve MV; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
  • Klein BS; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
  • Rajagopal J; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Vyas JM; Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, USA.
J Fungi (Basel) ; 9(1)2022 Dec 27.
Article em En | MEDLINE | ID: mdl-36675861
The lung epithelial lining serves as the primary barrier to inhaled environmental toxins, allergens, and invading pathogens. Pulmonary fungal infections are devastating and carry high mortality rates, particularly in those with compromised immune systems. While opportunistic fungi infect primarily immunocompromised individuals, endemic fungi cause disease in immune competent and compromised individuals. Unfortunately, in the case of inhaled fungal pathogens, the airway epithelial host response is vastly understudied. Furthering our lack of understanding, very few studies utilize primary human models displaying pseudostratified layers of various epithelial cell types at air-liquid interface. In this review, we focus on the diversity of the human airway epithelium and discuss the advantages and disadvantages of oncological cell lines, immortalized epithelial cells, and primary epithelial cell models. Additionally, the responses by human respiratory epithelial cells to invading fungal pathogens will be explored. Future investigations leveraging current human in vitro model systems will enable identification of the critical pathways that will inform the development of novel vaccines and therapeutics for pulmonary fungal infections.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Fungi (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Fungi (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça